UNSPSC 85881201: Tomographic (tomo) nuclear medicine imaging of skin, subcutaneous tissue and breast using other radionuclide

This classification denotes the group of activities that yields an intervention or procedure of tomographic (tomo) nuclear medicine imaging of skin, subcutaneous tissue and breast using other radionuclidetomographic (tomo) nuclear medicine imaging of skin, subcutaneous tissue and breast using other radionuclide. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CH2YYZZ

UNSPSC 85881201 Tomographic nuclear medicine imaging of skin, subcutaneous tissue and breast using other radionuclide is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The recent opportunities tagged under this code reflect a mismatch: San Mateo Medical Center's RFP for a Diagnostic Imaging PACS system addresses enterprise-grade picture archiving and communication infrastructure supporting radiology, cardiology, and mammography studies across multiple modalities, not tomographic nuclear medicine imaging specifically; Birdville Independent School District's RFQ for special education contracted services (audiologist, diagnostician, speech language therapist, physical therapist, and related roles) has no connection to nuclear medicine imaging; and Santa Clara Health System's multiple-award qualification vehicle for temporary health professional staffing across audiology, cardiology, radiology, and therapy services similarly reflects general ancillary clinical staffing rather than specialized nuclear medicine tomography.

State and local procurement bodies have not posted opportunities specifically requesting tomographic nuclear medicine imaging services, radiopharmaceuticals, or related diagnostic equipment under this code in the recent dataset. The code appears inactive or underutilized for its intended commodity class. Business development professionals evaluating this code should monitor whether health systems begin independently procuring nuclear medicine imaging capacity, or whether state Medicaid programs or public hospital consortia develop cooperative purchasing vehicles for advanced diagnostic imaging modalities — neither pattern is evident in current activity.